1. Home
  2. MBOT vs SLS Comparison

MBOT vs SLS Comparison

Compare MBOT & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBOT
  • SLS
  • Stock Information
  • Founded
  • MBOT 2010
  • SLS 2012
  • Country
  • MBOT United States
  • SLS United States
  • Employees
  • MBOT N/A
  • SLS N/A
  • Industry
  • MBOT Medical/Dental Instruments
  • SLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBOT Health Care
  • SLS Health Care
  • Exchange
  • MBOT Nasdaq
  • SLS Nasdaq
  • Market Cap
  • MBOT 79.2M
  • SLS 89.6M
  • IPO Year
  • MBOT N/A
  • SLS N/A
  • Fundamental
  • Price
  • MBOT $2.49
  • SLS $1.31
  • Analyst Decision
  • MBOT Strong Buy
  • SLS
  • Analyst Count
  • MBOT 1
  • SLS 0
  • Target Price
  • MBOT $9.00
  • SLS N/A
  • AVG Volume (30 Days)
  • MBOT 4.3M
  • SLS 1.1M
  • Earning Date
  • MBOT 05-14-2025
  • SLS 05-13-2025
  • Dividend Yield
  • MBOT N/A
  • SLS N/A
  • EPS Growth
  • MBOT N/A
  • SLS N/A
  • EPS
  • MBOT N/A
  • SLS N/A
  • Revenue
  • MBOT N/A
  • SLS N/A
  • Revenue This Year
  • MBOT N/A
  • SLS N/A
  • Revenue Next Year
  • MBOT N/A
  • SLS N/A
  • P/E Ratio
  • MBOT N/A
  • SLS N/A
  • Revenue Growth
  • MBOT N/A
  • SLS N/A
  • 52 Week Low
  • MBOT $0.82
  • SLS $0.77
  • 52 Week High
  • MBOT $3.38
  • SLS $1.84
  • Technical
  • Relative Strength Index (RSI)
  • MBOT 71.60
  • SLS 66.32
  • Support Level
  • MBOT $1.35
  • SLS $0.95
  • Resistance Level
  • MBOT $2.38
  • SLS $1.36
  • Average True Range (ATR)
  • MBOT 0.28
  • SLS 0.08
  • MACD
  • MBOT 0.11
  • SLS 0.03
  • Stochastic Oscillator
  • MBOT 88.37
  • SLS 87.80

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: